SHL Telemedicine Ltd. (SHLT)

Market Cap	88.19M
Revenue (ttm)	57.08M
Net Income (ttm)	-7.06M
Shares Out	16.39M
EPS (ttm)	-0.54
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1
Open	5.54
Previous Close	5.47
Day's Range	5.38 - 5.54
52-Week Range	4.86 - 12.75
Beta	0.32
Analysts	Strong Buy
Price Target	11.00 (+104.46%)
Earnings Date	Sep 21, 2023

About SHLT

SHL Telemedicine Ltd., together with its subsidiaries, develops and markets personal telemedicine solutions in Israel, Europe, and internationally. It offers smartheart, a personal mobile 12 lead ECG device that enables the detection of heart attacks; CardioSen'C, a personal cellular-digital 12-lead ECG transmitter device; Cardio'B, a portable device to transmit a 12-lead ECG; and Cardio Beeper 12/12, a hand-held ECG transmitter device for personal use that transmits a full ECG reading to the monitoring center. The company also provides central...

• Industry: Health Information Services
• Sector: Healthcare
• Founded: 1987
• Employees: 402
• Stock Exchange: NASDAQ
• Ticker Symbol: SHLT

Financial Performance

In 2023, SHLT's revenue was $57.08 million, a decrease of -3.26% compared to the previous year's $59.00 million. Losses were -$7.06 million, 9184.2% more than in 2022.

Analyst Forecast

According to one analyst, the rating for SHLT stock is "Strong Buy" and the 12-month stock price forecast is $11.0.

Price Target

$11.0

(104.46% upside)

Analyst Consensus: Strong Buy